Tetratherix (TTX), Australia’s own ‘medical Lego’
Rebekah Van der Kooy
July 1, 2025
Tetratherix (ASX:TTX) lists its IPO at the end of June
Tetratherix is a start-up biotech company specialising in regenerative medicine through their medical platform technology. The company listed on the ASX in June 2025.
Tetratherix (ASX:TTX) lists its IPO at the end of June
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.